← All trials
NCT07256912
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2026
- Primary completion
- Nov 1, 2028
- Completion date
- Jan 15, 2029
- First posted
- Dec 1, 2025
- Last posted
- Dec 1, 2025
- Enrollment
- 1266
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- International Agency for Research on CancerLead sponsor
- International Agency for Research on CancerSponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.